Currently, the use of drugs possessing AMPK-activating properties or upregulation of AMPK upstream-activated proteins offers a novel clinical strategy for enhancing mitochondrial biogenesis in the treatment and prevention of diseases
Genetic testing potentially identifying optimal responders though not currently standard practice
In this scenario, taking a standard glutathione pill is essentially like taking a very expensive amino acid supplement
Mastroberardino Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
TNF-: tumor necrosis factor-alpha
doi: 10.3390/nu11092073 26